Loading…

Polyoxometalates as potent inhibitors for acetyl and butyrylcholinesterases and as potential drugs for the treatment of Alzheimer’s disease

Polyoxometalates (POMs) show significant importance in medicine due to their enzyme inhibition, antiviral and anticancer properties. In this study, some polyoxotungstates were identified as potent inhibitors of acetyl and butyrylcholinesterases. Compounds [H 2 W 12 O 42 ] 10− and [TeW 6 O 24 ] 6− ha...

Full description

Saved in:
Bibliographic Details
Published in:Medicinal chemistry research 2013-03, Vol.22 (3), p.1224-1228
Main Authors: Iqbal, Jamshed, Barsukova-Stuckart, Maria, Ibrahim, Masooma, Ali, Syed Usman, Khan, Aftab Ahmed, Kortz, Ulrich
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c359t-844e9d3b3074ed6b63188d53ede7f5a3d8dc0bf458308ba7b2e92634c9727d813
cites cdi_FETCH-LOGICAL-c359t-844e9d3b3074ed6b63188d53ede7f5a3d8dc0bf458308ba7b2e92634c9727d813
container_end_page 1228
container_issue 3
container_start_page 1224
container_title Medicinal chemistry research
container_volume 22
creator Iqbal, Jamshed
Barsukova-Stuckart, Maria
Ibrahim, Masooma
Ali, Syed Usman
Khan, Aftab Ahmed
Kortz, Ulrich
description Polyoxometalates (POMs) show significant importance in medicine due to their enzyme inhibition, antiviral and anticancer properties. In this study, some polyoxotungstates were identified as potent inhibitors of acetyl and butyrylcholinesterases. Compounds [H 2 W 12 O 42 ] 10− and [TeW 6 O 24 ] 6− have the most potent acetylcholinesterase activity, exhibiting IC 50 values of 0.29 ± 0.01 and 0.31 ± 0.01 μM, respectively. Whereas, compound [(O 3 PCH 2 PO 3 ) 4 W 12 O 36 ] 16− was a potent and selective inhibitor of butyrylcholinesterase with IC 50 value of 0.18 ± 0.05 μM. In general, POMs were found to be effective cholinesterase inhibitors in terms of efficiency as well as selectivity and represent non-classical cholinesterase inhibitors.
doi_str_mv 10.1007/s00044-012-0125-8
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2404396005</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2404396005</sourcerecordid><originalsourceid>FETCH-LOGICAL-c359t-844e9d3b3074ed6b63188d53ede7f5a3d8dc0bf458308ba7b2e92634c9727d813</originalsourceid><addsrcrecordid>eNp1kM9Kw0AQxoMoWKsP4G3Bc3T2X7M5luI_KOhBz2GTnbQpabbubsF48gV8AF_PJ3FDRE8ehhmY7_cN8yXJOYVLCpBdeQAQIgXKhpKpOkgmVEqRKsrgMM4QZyYZP05OvN8A8AyEnCQfj7bt7avdYtCtDuiJ9mRnA3aBNN26KZtgnSe1dURXGPqW6M6Qch9617fV2rZNhz6g035A4-oXb3RLjNuvRjiskQSHOmwHZ1uTefu2xmaL7uv90xPTeIwWp8lRrVuPZz99mjzfXD8t7tLlw-39Yr5MKy7zkCohMDe85JAJNLNyxqlSRnI0mNVSc6NMBWUtpOKgSp2VDHM246LKM5YZRfk0uRh9d86-7OMDxcbuXRdPFkyA4PkMQEYVHVWVs947rIuda7ba9QWFYki9GFMvYuJDyUJFho2Mj9puhe7P-X_oG3LaiTU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2404396005</pqid></control><display><type>article</type><title>Polyoxometalates as potent inhibitors for acetyl and butyrylcholinesterases and as potential drugs for the treatment of Alzheimer’s disease</title><source>Springer Nature</source><creator>Iqbal, Jamshed ; Barsukova-Stuckart, Maria ; Ibrahim, Masooma ; Ali, Syed Usman ; Khan, Aftab Ahmed ; Kortz, Ulrich</creator><creatorcontrib>Iqbal, Jamshed ; Barsukova-Stuckart, Maria ; Ibrahim, Masooma ; Ali, Syed Usman ; Khan, Aftab Ahmed ; Kortz, Ulrich</creatorcontrib><description>Polyoxometalates (POMs) show significant importance in medicine due to their enzyme inhibition, antiviral and anticancer properties. In this study, some polyoxotungstates were identified as potent inhibitors of acetyl and butyrylcholinesterases. Compounds [H 2 W 12 O 42 ] 10− and [TeW 6 O 24 ] 6− have the most potent acetylcholinesterase activity, exhibiting IC 50 values of 0.29 ± 0.01 and 0.31 ± 0.01 μM, respectively. Whereas, compound [(O 3 PCH 2 PO 3 ) 4 W 12 O 36 ] 16− was a potent and selective inhibitor of butyrylcholinesterase with IC 50 value of 0.18 ± 0.05 μM. In general, POMs were found to be effective cholinesterase inhibitors in terms of efficiency as well as selectivity and represent non-classical cholinesterase inhibitors.</description><identifier>ISSN: 1054-2523</identifier><identifier>EISSN: 1554-8120</identifier><identifier>DOI: 10.1007/s00044-012-0125-8</identifier><language>eng</language><publisher>New York: Springer-Verlag</publisher><subject>Acetylcholinesterase ; Alzheimer's disease ; Anticancer properties ; Antiviral activity ; Antiviral agents ; Biochemistry ; Biomedical and Life Sciences ; Biomedicine ; Cell Biology ; Cholinesterase ; Cholinesterase inhibitors ; Inhibitors ; Neurodegenerative diseases ; Original Research ; Pharmacology/Toxicology ; Polyoxometallates ; Selectivity</subject><ispartof>Medicinal chemistry research, 2013-03, Vol.22 (3), p.1224-1228</ispartof><rights>Springer Science+Business Media, LLC 2012</rights><rights>Springer Science+Business Media, LLC 2012.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c359t-844e9d3b3074ed6b63188d53ede7f5a3d8dc0bf458308ba7b2e92634c9727d813</citedby><cites>FETCH-LOGICAL-c359t-844e9d3b3074ed6b63188d53ede7f5a3d8dc0bf458308ba7b2e92634c9727d813</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids></links><search><creatorcontrib>Iqbal, Jamshed</creatorcontrib><creatorcontrib>Barsukova-Stuckart, Maria</creatorcontrib><creatorcontrib>Ibrahim, Masooma</creatorcontrib><creatorcontrib>Ali, Syed Usman</creatorcontrib><creatorcontrib>Khan, Aftab Ahmed</creatorcontrib><creatorcontrib>Kortz, Ulrich</creatorcontrib><title>Polyoxometalates as potent inhibitors for acetyl and butyrylcholinesterases and as potential drugs for the treatment of Alzheimer’s disease</title><title>Medicinal chemistry research</title><addtitle>Med Chem Res</addtitle><description>Polyoxometalates (POMs) show significant importance in medicine due to their enzyme inhibition, antiviral and anticancer properties. In this study, some polyoxotungstates were identified as potent inhibitors of acetyl and butyrylcholinesterases. Compounds [H 2 W 12 O 42 ] 10− and [TeW 6 O 24 ] 6− have the most potent acetylcholinesterase activity, exhibiting IC 50 values of 0.29 ± 0.01 and 0.31 ± 0.01 μM, respectively. Whereas, compound [(O 3 PCH 2 PO 3 ) 4 W 12 O 36 ] 16− was a potent and selective inhibitor of butyrylcholinesterase with IC 50 value of 0.18 ± 0.05 μM. In general, POMs were found to be effective cholinesterase inhibitors in terms of efficiency as well as selectivity and represent non-classical cholinesterase inhibitors.</description><subject>Acetylcholinesterase</subject><subject>Alzheimer's disease</subject><subject>Anticancer properties</subject><subject>Antiviral activity</subject><subject>Antiviral agents</subject><subject>Biochemistry</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Cell Biology</subject><subject>Cholinesterase</subject><subject>Cholinesterase inhibitors</subject><subject>Inhibitors</subject><subject>Neurodegenerative diseases</subject><subject>Original Research</subject><subject>Pharmacology/Toxicology</subject><subject>Polyoxometallates</subject><subject>Selectivity</subject><issn>1054-2523</issn><issn>1554-8120</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNp1kM9Kw0AQxoMoWKsP4G3Bc3T2X7M5luI_KOhBz2GTnbQpabbubsF48gV8AF_PJ3FDRE8ehhmY7_cN8yXJOYVLCpBdeQAQIgXKhpKpOkgmVEqRKsrgMM4QZyYZP05OvN8A8AyEnCQfj7bt7avdYtCtDuiJ9mRnA3aBNN26KZtgnSe1dURXGPqW6M6Qch9617fV2rZNhz6g035A4-oXb3RLjNuvRjiskQSHOmwHZ1uTefu2xmaL7uv90xPTeIwWp8lRrVuPZz99mjzfXD8t7tLlw-39Yr5MKy7zkCohMDe85JAJNLNyxqlSRnI0mNVSc6NMBWUtpOKgSp2VDHM246LKM5YZRfk0uRh9d86-7OMDxcbuXRdPFkyA4PkMQEYVHVWVs947rIuda7ba9QWFYki9GFMvYuJDyUJFho2Mj9puhe7P-X_oG3LaiTU</recordid><startdate>20130301</startdate><enddate>20130301</enddate><creator>Iqbal, Jamshed</creator><creator>Barsukova-Stuckart, Maria</creator><creator>Ibrahim, Masooma</creator><creator>Ali, Syed Usman</creator><creator>Khan, Aftab Ahmed</creator><creator>Kortz, Ulrich</creator><general>Springer-Verlag</general><general>Springer Nature B.V</general><scope>AAYXX</scope><scope>CITATION</scope><scope>8FD</scope><scope>FR3</scope><scope>M7Z</scope><scope>P64</scope></search><sort><creationdate>20130301</creationdate><title>Polyoxometalates as potent inhibitors for acetyl and butyrylcholinesterases and as potential drugs for the treatment of Alzheimer’s disease</title><author>Iqbal, Jamshed ; Barsukova-Stuckart, Maria ; Ibrahim, Masooma ; Ali, Syed Usman ; Khan, Aftab Ahmed ; Kortz, Ulrich</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c359t-844e9d3b3074ed6b63188d53ede7f5a3d8dc0bf458308ba7b2e92634c9727d813</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Acetylcholinesterase</topic><topic>Alzheimer's disease</topic><topic>Anticancer properties</topic><topic>Antiviral activity</topic><topic>Antiviral agents</topic><topic>Biochemistry</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Cell Biology</topic><topic>Cholinesterase</topic><topic>Cholinesterase inhibitors</topic><topic>Inhibitors</topic><topic>Neurodegenerative diseases</topic><topic>Original Research</topic><topic>Pharmacology/Toxicology</topic><topic>Polyoxometallates</topic><topic>Selectivity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Iqbal, Jamshed</creatorcontrib><creatorcontrib>Barsukova-Stuckart, Maria</creatorcontrib><creatorcontrib>Ibrahim, Masooma</creatorcontrib><creatorcontrib>Ali, Syed Usman</creatorcontrib><creatorcontrib>Khan, Aftab Ahmed</creatorcontrib><creatorcontrib>Kortz, Ulrich</creatorcontrib><collection>CrossRef</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biochemistry Abstracts 1</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Medicinal chemistry research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Iqbal, Jamshed</au><au>Barsukova-Stuckart, Maria</au><au>Ibrahim, Masooma</au><au>Ali, Syed Usman</au><au>Khan, Aftab Ahmed</au><au>Kortz, Ulrich</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Polyoxometalates as potent inhibitors for acetyl and butyrylcholinesterases and as potential drugs for the treatment of Alzheimer’s disease</atitle><jtitle>Medicinal chemistry research</jtitle><stitle>Med Chem Res</stitle><date>2013-03-01</date><risdate>2013</risdate><volume>22</volume><issue>3</issue><spage>1224</spage><epage>1228</epage><pages>1224-1228</pages><issn>1054-2523</issn><eissn>1554-8120</eissn><abstract>Polyoxometalates (POMs) show significant importance in medicine due to their enzyme inhibition, antiviral and anticancer properties. In this study, some polyoxotungstates were identified as potent inhibitors of acetyl and butyrylcholinesterases. Compounds [H 2 W 12 O 42 ] 10− and [TeW 6 O 24 ] 6− have the most potent acetylcholinesterase activity, exhibiting IC 50 values of 0.29 ± 0.01 and 0.31 ± 0.01 μM, respectively. Whereas, compound [(O 3 PCH 2 PO 3 ) 4 W 12 O 36 ] 16− was a potent and selective inhibitor of butyrylcholinesterase with IC 50 value of 0.18 ± 0.05 μM. In general, POMs were found to be effective cholinesterase inhibitors in terms of efficiency as well as selectivity and represent non-classical cholinesterase inhibitors.</abstract><cop>New York</cop><pub>Springer-Verlag</pub><doi>10.1007/s00044-012-0125-8</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1054-2523
ispartof Medicinal chemistry research, 2013-03, Vol.22 (3), p.1224-1228
issn 1054-2523
1554-8120
language eng
recordid cdi_proquest_journals_2404396005
source Springer Nature
subjects Acetylcholinesterase
Alzheimer's disease
Anticancer properties
Antiviral activity
Antiviral agents
Biochemistry
Biomedical and Life Sciences
Biomedicine
Cell Biology
Cholinesterase
Cholinesterase inhibitors
Inhibitors
Neurodegenerative diseases
Original Research
Pharmacology/Toxicology
Polyoxometallates
Selectivity
title Polyoxometalates as potent inhibitors for acetyl and butyrylcholinesterases and as potential drugs for the treatment of Alzheimer’s disease
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T12%3A56%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Polyoxometalates%20as%20potent%20inhibitors%20for%20acetyl%20and%20butyrylcholinesterases%20and%20as%20potential%20drugs%20for%20the%20treatment%20of%20Alzheimer%E2%80%99s%20disease&rft.jtitle=Medicinal%20chemistry%20research&rft.au=Iqbal,%20Jamshed&rft.date=2013-03-01&rft.volume=22&rft.issue=3&rft.spage=1224&rft.epage=1228&rft.pages=1224-1228&rft.issn=1054-2523&rft.eissn=1554-8120&rft_id=info:doi/10.1007/s00044-012-0125-8&rft_dat=%3Cproquest_cross%3E2404396005%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c359t-844e9d3b3074ed6b63188d53ede7f5a3d8dc0bf458308ba7b2e92634c9727d813%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2404396005&rft_id=info:pmid/&rfr_iscdi=true